Gerry Farber’s Biogen BIIB Stock Holding History

Gerry Farber’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,920	Closed	-$1.24M	–	34
2014 Q2	$1.24M	Buy	+3,920	New	+$1.18M	1.28%	32
2013 Q3	–	Sell	-4,600	Closed	-$990K	–	81
2013 Q2	$990K	Buy	+4,600	New	+$983K	1%	52

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Gerry Farber's BIIB Position: Q3 2014 in Review

Gerry Farber sold out of Biogen (BIIB) in Q3 2014, closing a stake of 3,920 shares — an estimated $1.24M sold.

Gerry Farber first reported a position in BIIB in Q2 2013 and held it in 2 quarters. The position peaked at $1.24M in Q2 2014. 818 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

Gerry Farber reported no remaining Biogen position as of Q3 2014 after selling out during the quarter.
Gerry Farber sold 3,920 Biogen shares in Q3 2014, an estimated $1.24M.
Gerry Farber first reported a position in Biogen in Q2 2013 and held it in 2 quarters.
Gerry Farber's Biogen position peaked at $1.24M in Q2 2014.
818 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on Gerry Farber's 13F filing for Q3 2014, filed 17 Oct 2014.